PTC Therapeutics, Inc. (PTCT) Net income 2016–2025
PTC Therapeutics, Inc. (PTCT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$683.0MFY2025 · since FY2016: -$142.1M → $683.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $683.0M | +288.0% |
| FY2024 | -$363.3M | +42.0% |
| FY2023 | -$626.6M | -12.1% |
| FY2022 | -$559.0M | -6.7% |
| FY2021 | -$523.9M | -19.6% |
| FY2020 | -$438.2M | -74.2% |
| FY2019 | -$251.6M | -96.4% |
| FY2018 | -$128.1M | -62.1% |
| FY2017 | -$79.0M | +44.4% |
| FY2016 | -$142.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice